The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Diacerein, C19H12O8, is an important inhibitor of osteoarthritis il-1.Double red vinegar by and diacetyl dihydrogen anthracene carboxylic acid, 1, 8 - acetyl 2-3 - carboxylic acid anthraquinone, ceri English, artodar, is a new inhibitor, interleukin (IL) - 1 chemical name for diacetyl rhein, belong to the compound of anthraquinones, this product can induce cartilage formation, have analgesic, anti-inflammatory and antifebrile effect, can significantly improve the joint function in patients with osteoarthritis, delay the course of the disease, relieve pain, improve the patient's quality of life, has good safety, clinical mainly used in the treatment of osteoarthritis (OA) and play a role of antibacterial.
The global Diacerein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Diacerein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diacerein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diacerein include TRB Pharma, Novartis, TWi Pharma, Zydus Pharmaceuticals/Cadila Pharma, Glenmark Pharmaceutical, Castle Creek Pharma, Proter, Rottapharm and Abiogen Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diacerein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diacerein.
Report Scope
The Diacerein market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diacerein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diacerein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TRB Pharma
Novartis
TWi Pharma
Zydus Pharmaceuticals/Cadila Pharma
Glenmark Pharmaceutical
Castle Creek Pharma
Proter
Rottapharm
Abiogen Pharma
Segment by Type
Combination Drugs
Prescribed Drugs
Segment by Application
Arthritis
Musculoskeletal Pain
Bullae Epidermolysis
Pemphigus
Pemphigoid
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diacerein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diacerein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diacerein, C19H12O8, is an important inhibitor of osteoarthritis il-1.Double red vinegar by and diacetyl dihydrogen anthracene carboxylic acid, 1, 8 - acetyl 2-3 - carboxylic acid anthraquinone, ceri English, artodar, is a new inhibitor, interleukin (IL) - 1 chemical name for diacetyl rhein, belong to the compound of anthraquinones, this product can induce cartilage formation, have analgesic, anti-inflammatory and antifebrile effect, can significantly improve the joint function in patients with osteoarthritis, delay the course of the disease, relieve pain, improve the patient's quality of life, has good safety, clinical mainly used in the treatment of osteoarthritis (OA) and play a role of antibacterial.
The global Diacerein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Diacerein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diacerein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diacerein include TRB Pharma, Novartis, TWi Pharma, Zydus Pharmaceuticals/Cadila Pharma, Glenmark Pharmaceutical, Castle Creek Pharma, Proter, Rottapharm and Abiogen Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diacerein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diacerein.
Report Scope
The Diacerein market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diacerein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diacerein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TRB Pharma
Novartis
TWi Pharma
Zydus Pharmaceuticals/Cadila Pharma
Glenmark Pharmaceutical
Castle Creek Pharma
Proter
Rottapharm
Abiogen Pharma
Segment by Type
Combination Drugs
Prescribed Drugs
Segment by Application
Arthritis
Musculoskeletal Pain
Bullae Epidermolysis
Pemphigus
Pemphigoid
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diacerein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diacerein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diacerein Market Overview
1.1 Product Overview and Scope of Diacerein
1.2 Diacerein Segment by Type
1.2.1 Global Diacerein Market Value Comparison by Type (2024-2030)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Diacerein Segment by Application
1.3.1 Global Diacerein Market Value by Application: (2024-2030)
1.3.2 Arthritis
1.3.3 Musculoskeletal Pain
1.3.4 Bullae Epidermolysis
1.3.5 Pemphigus
1.3.6 Pemphigoid
1.3.7 Other
1.4 Global Diacerein Market Size Estimates and Forecasts
1.4.1 Global Diacerein Revenue 2019-2030
1.4.2 Global Diacerein Sales 2019-2030
1.4.3 Global Diacerein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diacerein Market Competition by Manufacturers
2.1 Global Diacerein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diacerein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diacerein Average Price by Manufacturers (2019-2024)
2.4 Global Diacerein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diacerein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diacerein, Product Type & Application
2.7 Diacerein Market Competitive Situation and Trends
2.7.1 Diacerein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diacerein Players Market Share by Revenue
2.7.3 Global Diacerein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diacerein Retrospective Market Scenario by Region
3.1 Global Diacerein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diacerein Global Diacerein Sales by Region: 2019-2030
3.2.1 Global Diacerein Sales by Region: 2019-2024
3.2.2 Global Diacerein Sales by Region: 2025-2030
3.3 Global Diacerein Global Diacerein Revenue by Region: 2019-2030
3.3.1 Global Diacerein Revenue by Region: 2019-2024
3.3.2 Global Diacerein Revenue by Region: 2025-2030
3.4 North America Diacerein Market Facts & Figures by Country
3.4.1 North America Diacerein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diacerein Sales by Country (2019-2030)
3.4.3 North America Diacerein Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diacerein Market Facts & Figures by Country
3.5.1 Europe Diacerein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diacerein Sales by Country (2019-2030)
3.5.3 Europe Diacerein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diacerein Market Facts & Figures by Country
3.6.1 Asia Pacific Diacerein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diacerein Sales by Country (2019-2030)
3.6.3 Asia Pacific Diacerein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diacerein Market Facts & Figures by Country
3.7.1 Latin America Diacerein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diacerein Sales by Country (2019-2030)
3.7.3 Latin America Diacerein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diacerein Market Facts & Figures by Country
3.8.1 Middle East and Africa Diacerein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diacerein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diacerein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diacerein Sales by Type (2019-2030)
4.1.1 Global Diacerein Sales by Type (2019-2024)
4.1.2 Global Diacerein Sales by Type (2025-2030)
4.1.3 Global Diacerein Sales Market Share by Type (2019-2030)
4.2 Global Diacerein Revenue by Type (2019-2030)
4.2.1 Global Diacerein Revenue by Type (2019-2024)
4.2.2 Global Diacerein Revenue by Type (2025-2030)
4.2.3 Global Diacerein Revenue Market Share by Type (2019-2030)
4.3 Global Diacerein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diacerein Sales by Application (2019-2030)
5.1.1 Global Diacerein Sales by Application (2019-2024)
5.1.2 Global Diacerein Sales by Application (2025-2030)
5.1.3 Global Diacerein Sales Market Share by Application (2019-2030)
5.2 Global Diacerein Revenue by Application (2019-2030)
5.2.1 Global Diacerein Revenue by Application (2019-2024)
5.2.2 Global Diacerein Revenue by Application (2025-2030)
5.2.3 Global Diacerein Revenue Market Share by Application (2019-2030)
5.3 Global Diacerein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 TRB Pharma
6.1.1 TRB Pharma Corporation Information
6.1.2 TRB Pharma Description and Business Overview
6.1.3 TRB Pharma Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 TRB Pharma Diacerein Product Portfolio
6.1.5 TRB Pharma Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Diacerein Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 TWi Pharma
6.3.1 TWi Pharma Corporation Information
6.3.2 TWi Pharma Description and Business Overview
6.3.3 TWi Pharma Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TWi Pharma Diacerein Product Portfolio
6.3.5 TWi Pharma Recent Developments/Updates
6.4 Zydus Pharmaceuticals/Cadila Pharma
6.4.1 Zydus Pharmaceuticals/Cadila Pharma Corporation Information
6.4.2 Zydus Pharmaceuticals/Cadila Pharma Description and Business Overview
6.4.3 Zydus Pharmaceuticals/Cadila Pharma Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Pharmaceuticals/Cadila Pharma Diacerein Product Portfolio
6.4.5 Zydus Pharmaceuticals/Cadila Pharma Recent Developments/Updates
6.5 Glenmark Pharmaceutical
6.5.1 Glenmark Pharmaceutical Corporation Information
6.5.2 Glenmark Pharmaceutical Description and Business Overview
6.5.3 Glenmark Pharmaceutical Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Glenmark Pharmaceutical Diacerein Product Portfolio
6.5.5 Glenmark Pharmaceutical Recent Developments/Updates
6.6 Castle Creek Pharma
6.6.1 Castle Creek Pharma Corporation Information
6.6.2 Castle Creek Pharma Description and Business Overview
6.6.3 Castle Creek Pharma Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Castle Creek Pharma Diacerein Product Portfolio
6.6.5 Castle Creek Pharma Recent Developments/Updates
6.7 Proter
6.6.1 Proter Corporation Information
6.6.2 Proter Description and Business Overview
6.6.3 Proter Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Proter Diacerein Product Portfolio
6.7.5 Proter Recent Developments/Updates
6.8 Rottapharm
6.8.1 Rottapharm Corporation Information
6.8.2 Rottapharm Description and Business Overview
6.8.3 Rottapharm Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Rottapharm Diacerein Product Portfolio
6.8.5 Rottapharm Recent Developments/Updates
6.9 Abiogen Pharma
6.9.1 Abiogen Pharma Corporation Information
6.9.2 Abiogen Pharma Description and Business Overview
6.9.3 Abiogen Pharma Diacerein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abiogen Pharma Diacerein Product Portfolio
6.9.5 Abiogen Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diacerein Industry Chain Analysis
7.2 Diacerein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diacerein Production Mode & Process
7.4 Diacerein Sales and Marketing
7.4.1 Diacerein Sales Channels
7.4.2 Diacerein Distributors
7.5 Diacerein Customers
8 Diacerein Market Dynamics
8.1 Diacerein Industry Trends
8.2 Diacerein Market Drivers
8.3 Diacerein Market Challenges
8.4 Diacerein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Diacerein Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diacerein Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Diacerein Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diacerein Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Diacerein Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diacerein Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diacerein Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diacerein Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diacerein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diacerein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diacerein, Product Type & Application
Table 12. Global Key Manufacturers of Diacerein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diacerein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diacerein as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diacerein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diacerein Sales by Region (2019-2024) & (KG)
Table 18. Global Diacerein Sales Market Share by Region (2019-2024)
Table 19. Global Diacerein Sales by Region (2025-2030) & (KG)
Table 20. Global Diacerein Sales Market Share by Region (2025-2030)
Table 21. Global Diacerein Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diacerein Revenue Market Share by Region (2019-2024)
Table 23. Global Diacerein Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diacerein Revenue Market Share by Region (2025-2030)
Table 25. North America Diacerein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diacerein Sales by Country (2019-2024) & (KG)
Table 27. North America Diacerein Sales by Country (2025-2030) & (KG)
Table 28. North America Diacerein Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diacerein Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diacerein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diacerein Sales by Country (2019-2024) & (KG)
Table 32. Europe Diacerein Sales by Country (2025-2030) & (KG)
Table 33. Europe Diacerein Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diacerein Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diacerein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diacerein Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Diacerein Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Diacerein Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diacerein Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diacerein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diacerein Sales by Country (2019-2024) & (KG)
Table 42. Latin America Diacerein Sales by Country (2025-2030) & (KG)
Table 43. Latin America Diacerein Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diacerein Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diacerein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Diacerein Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Diacerein Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Diacerein Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Diacerein Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diacerein Sales (KG) by Type (2019-2024)
Table 51. Global Diacerein Sales (KG) by Type (2025-2030)
Table 52. Global Diacerein Sales Market Share by Type (2019-2024)
Table 53. Global Diacerein Sales Market Share by Type (2025-2030)
Table 54. Global Diacerein Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diacerein Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diacerein Revenue Market Share by Type (2019-2024)
Table 57. Global Diacerein Revenue Market Share by Type (2025-2030)
Table 58. Global Diacerein Price (US$/G) by Type (2019-2024)
Table 59. Global Diacerein Price (US$/G) by Type (2025-2030)
Table 60. Global Diacerein Sales (KG) by Application (2019-2024)
Table 61. Global Diacerein Sales (KG) by Application (2025-2030)
Table 62. Global Diacerein Sales Market Share by Application (2019-2024)
Table 63. Global Diacerein Sales Market Share by Application (2025-2030)
Table 64. Global Diacerein Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diacerein Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diacerein Revenue Market Share by Application (2019-2024)
Table 67. Global Diacerein Revenue Market Share by Application (2025-2030)
Table 68. Global Diacerein Price (US$/G) by Application (2019-2024)
Table 69. Global Diacerein Price (US$/G) by Application (2025-2030)
Table 70. TRB Pharma Corporation Information
Table 71. TRB Pharma Description and Business Overview
Table 72. TRB Pharma Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. TRB Pharma Diacerein Product
Table 74. TRB Pharma Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Novartis Diacerein Product
Table 79. Novartis Recent Developments/Updates
Table 80. TWi Pharma Corporation Information
Table 81. TWi Pharma Description and Business Overview
Table 82. TWi Pharma Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. TWi Pharma Diacerein Product
Table 84. TWi Pharma Recent Developments/Updates
Table 85. Zydus Pharmaceuticals/Cadila Pharma Corporation Information
Table 86. Zydus Pharmaceuticals/Cadila Pharma Description and Business Overview
Table 87. Zydus Pharmaceuticals/Cadila Pharma Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Zydus Pharmaceuticals/Cadila Pharma Diacerein Product
Table 89. Zydus Pharmaceuticals/Cadila Pharma Recent Developments/Updates
Table 90. Glenmark Pharmaceutical Corporation Information
Table 91. Glenmark Pharmaceutical Description and Business Overview
Table 92. Glenmark Pharmaceutical Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Glenmark Pharmaceutical Diacerein Product
Table 94. Glenmark Pharmaceutical Recent Developments/Updates
Table 95. Castle Creek Pharma Corporation Information
Table 96. Castle Creek Pharma Description and Business Overview
Table 97. Castle Creek Pharma Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Castle Creek Pharma Diacerein Product
Table 99. Castle Creek Pharma Recent Developments/Updates
Table 100. Proter Corporation Information
Table 101. Proter Description and Business Overview
Table 102. Proter Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Proter Diacerein Product
Table 104. Proter Recent Developments/Updates
Table 105. Rottapharm Corporation Information
Table 106. Rottapharm Description and Business Overview
Table 107. Rottapharm Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Rottapharm Diacerein Product
Table 109. Rottapharm Recent Developments/Updates
Table 110. Abiogen Pharma Corporation Information
Table 111. Abiogen Pharma Description and Business Overview
Table 112. Abiogen Pharma Diacerein Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Abiogen Pharma Diacerein Product
Table 114. Abiogen Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Diacerein Distributors List
Table 118. Diacerein Customers List
Table 119. Diacerein Market Trends
Table 120. Diacerein Market Drivers
Table 121. Diacerein Market Challenges
Table 122. Diacerein Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diacerein
Figure 2. Global Diacerein Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diacerein Market Share by Type in 2023 & 2030
Figure 4. Combination Drugs Product Picture
Figure 5. Prescribed Drugs Product Picture
Figure 6. Global Diacerein Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Diacerein Market Share by Application in 2023 & 2030
Figure 8. Arthritis
Figure 9. Musculoskeletal Pain
Figure 10. Bullae Epidermolysis
Figure 11. Pemphigus
Figure 12. Pemphigoid
Figure 13. Other
Figure 14. Global Diacerein Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Diacerein Market Size (2019-2030) & (US$ Million)
Figure 16. Global Diacerein Sales (2019-2030) & (KG)
Figure 17. Global Diacerein Average Price (US$/G) & (2019-2030)
Figure 18. Diacerein Report Years Considered
Figure 19. Diacerein Sales Share by Manufacturers in 2023
Figure 20. Global Diacerein Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Diacerein Players: Market Share by Revenue in 2023
Figure 22. Diacerein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Diacerein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Diacerein Sales Market Share by Country (2019-2030)
Figure 25. North America Diacerein Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Diacerein Sales Market Share by Country (2019-2030)
Figure 29. Europe Diacerein Revenue Market Share by Country (2019-2030)
Figure 30. Germany Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Diacerein Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Diacerein Revenue Market Share by Region (2019-2030)
Figure 37. China Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Diacerein Sales Market Share by Country (2019-2030)
Figure 48. Latin America Diacerein Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Diacerein Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Diacerein Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Diacerein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Diacerein by Type (2019-2030)
Figure 58. Global Revenue Market Share of Diacerein by Type (2019-2030)
Figure 59. Global Diacerein Price (US$/G) by Type (2019-2030)
Figure 60. Global Sales Market Share of Diacerein by Application (2019-2030)
Figure 61. Global Revenue Market Share of Diacerein by Application (2019-2030)
Figure 62. Global Diacerein Price (US$/G) by Application (2019-2030)
Figure 63. Diacerein Value Chain
Figure 64. Diacerein Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
